Company research / ARAY

Accuray Inc (ARAY)

SEC name ACCURAY INC · CIK 0001138723 · Nasdaq · Surgical & Medical Instruments & Apparatus

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Jun 30

For the year ended 2026-06-30, Accuray Inc reported revenue of $401.95M. Revenue fell 12.3% from the prior annual period.

Key ratios (year ended 2026-06-30)

27.7%
Gross margin
-6.6%
Operating margin
-12.2%
Net margin
-118.0%
Return on year-end equity
-12.3%
Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form DEF 14A (proxy statement) · 2026-10-16

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

Period ended2026-06-302025-06-302024-06-302023-06-302022-06-302021-06-302020-06-302019-06-302018-06-302017-06-30
Revenue$401.95M$458.50M$446.55M$447.61M$429.91M$396.29M$382.93M$418.79M$404.90M$383.41M
Cost of Revenue$290.49M$311.54M$303.63M$293.64M$269.95M$236.78M$233.21M$256.13M$243.20M$242.07M
Gross Profit$111.45M$146.97M$142.92M$153.96M$159.96M$159.51M$149.72M$162.65M$161.69M$141.34M
R&D Expense$37.75M$47.94M$49.73M$57.13M$57.75M$52.73M$49.78M$56.49M$57.25M$49.92M
Operating Income-$26.44M$7.84M$504.0K$2.38M$8.15M$22.23M$12.54M$583.0K-$3.80M-$9.82M
Depreciation & Amortization$7.94M$6.15M$5.91M$4.53M$5.51M$6.39M$7.54M$10.49M$9.73M$18.04M
EBITDA-$18.50M$13.99M$6.41M$6.91M$13.66M$28.62M$20.08M$11.07M$5.93M$8.22M
Net Income-$49.19M-$1.59M-$15.54M-$9.28M-$5.35M-$6.31M$3.83M-$16.43M-$23.90M-$29.58M
EPS (Diluted)n/a-$0.02-$0.16-$0.10-$0.06-$0.07$0.04-$0.19-$0.28n/a
Total Assets$443.68M$470.24M$468.63M$479.21M$472.85M$480.10M$490.93M$438.18M$378.73M$406.46M
Total Liabilities$401.98M$389.07M$423.54M$425.56M$419.66M$411.26M$427.29M$388.31M$330.10M$359.93M
Long-Term Debt$147.87M$136.52M$172.16M$177.28M$180.47M$173.80M$189.31M$159.84M$131.08M$164.57M
Shareholders' Equity$41.70M$81.17M$45.08M$53.66M$53.19M$68.84M$63.63M$49.87M$48.63M$46.53M
Cash & Equivalents$40.62M$57.42M$68.57M$89.40M$88.74M$116.37M$107.58M$76.80M$83.08M$72.08M
Operating Cash Flow-$6.98M$2.86M-$11.90M$15.54M-$2.40M$38.51M-$1.47M-$29.64M$18.33M-$380.0K
Capital Expenditures$5.86M$4.27M$3.60M$12.61M$4.72M$2.32M$3.56M$4.31M$6.28M$5.03M
Free Cash Flow-$12.84M-$1.41M-$15.51M$2.92M-$7.12M$36.19M-$5.03M-$33.95M$12.05M-$5.41M
Share Repurchasesn/an/an/a$0$0$14.08M$0n/an/an/a
Shares Outstanding119.43M112.64M100.19M96.53M93.50M90.82M91.18M88.52M86.13M83.74M
Weighted Average Diluted Sharesn/a102.77M98.27M94.88M92.09M92.03M90.62M87.47M84.89Mn/a
EPS (Basic)-$0.40-$0.02-$0.16-$0.10-$0.06-$0.07$0.04-$0.19-$0.28n/a

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView